TY  - GEN
AU  - Bayet-Robert,Mathilde
AU  - Kwiatkowski,Fabrice
AU  - Leheurteur,Marianne
AU  - Gachon,Françoise
AU  - Planchat,Eloïse
AU  - Abrial,Catherine
AU  - Mouret-Reynier,Marie-Ange
AU  - Durando,Xavier
AU  - Barthomeuf,Chantal
AU  - Chollet,Philippe
TI  - Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer
SN  - 1555-8576
PY  - 2010///0615
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Breast Neoplasms, Male
KW  - Carcinoma
KW  - Curcumin
KW  - administration & dosage
KW  - Diarrhea
KW  - chemically induced
KW  - Docetaxel
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Feasibility Studies
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Leukopenia
KW  - Male
KW  - Maximum Tolerated Dose
KW  - Middle Aged
KW  - Neoplasm Metastasis
KW  - Neutropenia
KW  - Taxoids
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4161/cbt.9.1.10392
ER  -